Clarity RMS™ is a renal function monitoring system that continuously measures urine flow, automatically transmitting real-time data, and notifications of fluctuations, on a 24/7 basis. This information provides an early sign of AKI risk and facilitates rapid intervention. In addition, it is invaluable for monitoring treatment efficacy and managing fluid balance.
In the ICU, time is of the essence.
Especially for patients at risk of Acute Kidney Injury (AKI).
Renal function monitoring is critical for early detection of changes and prevention of disease progression.
Real-time data: from bedside to clinicians
Automatic
Measurements
No manual intervention; Reduced risk of contamination; Not subject to human error
Reliable
Data
Accurate, direct readings of actual urine flow at catheter entry point
Full
Connectivity
Continuous transmission of
the data to all hospital
information systems
Real-Time
Notifications
Notifies medical staff of
suboptimal urine flow rate,
based on the RIFLE, AKIN,
and KDIGO criteria
The Impact of ICU-Acquired AKI
57%
of ICUÂ patients
develop AKI
Mortality rate
is increased
is increased
5-foldin ICUÂ patients
with AKI
with AKI
Renal Function Monitoring with the Clarity RMS
Better Medical Care
- Early detection of changes in renal function and AKI risk
- Early intervention to prevent disease progression
- Real-time monitoring of treatment efficacy & fluid management
Better ICU Economics
- Reduced length of ICU stay & readmissions
- Reduced ICU costs
- Improved ICU efficiency & performance
This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement no 882261.